Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
  1. 4 Grant or award Chief Medical Officer acquired 1,076 shares (grant or award)
  2. 4 Grant or award Chief Scientific Officer acquired 732 shares (grant or award)
  3. 4 Grant or award Chief Financial Officer acquired 1,366 shares (grant or award)
  4. 4 Shares withheld for taxes President and CEO gave up 3,007 shares (to pay taxes)
  5. 4 Open-market sale Chief Scientific Officer sold 37,164 shares at $12.00 ($445,968)
  6. 4 Shares withheld for taxes President and CEO gave up 3,007 shares (to pay taxes)
  7. 4 Open-market sale Chief Scientific Officer sold 5,462 shares at $12.00 ($65,546)
  8. 4 Open-market sale Chief Scientific Officer sold 37,352 shares at $12.00 ($448,254)
  9. 4 Open-market sale Director sold 17,610 shares at $11.75 ($206,944)
  10. 4 Option exercise Director acquired 279 shares (option exercise)
  11. 4 Open-market buy Director bought 1,000 shares at $8.00 ($8,000)
  12. 4 Shares withheld for taxes President and CEO gave up 3,008 shares (to pay taxes)
  13. 4 Open-market buy Director bought 1,200 shares at $4.50 ($5,400)
  14. 4 Shares withheld for taxes President and CEO gave up 3,008 shares (to pay taxes)
  15. 4 Shares withheld for taxes President and CEO gave up 3,007 shares (to pay taxes)
  16. 4 Open-market sale Chief Medical Officer sold 30,000 shares at $7.52 ($225,600)
  17. 4 Shares withheld for taxes President and CEO gave up 3,007 shares (to pay taxes)
  18. 4/A Derivatives Options or other derivatives
  19. 5 Insider Annual Insider Trading Report
  20. 4 Shares withheld for taxes Chief Medical Officer gave up 2,183 shares (to pay taxes)

Page 9 of 34 · 674 filings